It's an unfortunate truth that most people spend the lion's share of their waking hours at their jobs. Or at least, that's an ...
The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果